Achieve Life Sciences, Inc. ACHV 深 滬
已收盤 05-08 16:00:00 美东时间
5.21
+0.420
+8.77%
華盛通- 最 高5.35
- 今 開4.81
- 成交量 175.97万股
- 最 低 4.74
- 昨 收 4.79
- 總市值 5.35亿
- 52周最高 6.025
- 市盈率 靜 --
- 換手率 1.71%
- 52周最低 2.00
- 委 比 53.07%
- 總股本 1.03亿
- 歷史最高 970.00
- 量 比 2.14
- 振 幅 12.73%
- 歷史最低 1.84
- 每 手 1
- 風險率 0.92%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 瑞银大幅上调西部数据、希捷科技目标价！汇丰银行上调英特尔评级至"买入"，目标价从50美元升至95美元
今日重点评级关注：HC Wainwright & Co.：维持Century Therapeutics"买入"评级，目标价从2美元升至5美元；Oppenheimer：维持Climb Bio"跑赢大市"评级，目标价从10美元升至18美元
04-22 12:41
美股牛股 | Arxis上市首日涨超38%，公司为航空航天及国防电子元件制造商；量子计算概念股XNDU再涨近30%
Arxis上市首日涨超38%，公司为航空航天及国防电子元件制造商；量子计算概念股XNDU再涨近30%；医疗概念股CareDx涨超27%，剥离实验室产品业务以聚焦核心业务>>
04-17 19:07
Achieve Life Sciences Transfers Cystisinicline Manufacturing To Adare Pharma Solutions; Manufactures First Cytisinicline Engineering Batch At Adare
Adare Partnership Provides Supply Chain Redundancy and U.S.-based Manufacturing CapabilityCompany Reiterates Guidance - If Approved, Cytisinicline Commercial Launch Expected in First Half of 2027
04-15 20:04
美股大行评级 | 最高240美元，潜在涨幅53%！ARM获多家大行上调目标价；Braze 评级上演 “两极反转”，小摩、巴克莱上调，高盛、花旗下调
今日重点评级关注：HC Wainwright & Co.：维持OCUGEN"买入"评级，目标价从7美元升至10美元；HC Wainwright & Co.：维持Maze Therapeutics"买入"评级，目标价从60美元升至110美元
03-26 11:41
Achieve Life Sciences shares are trading lower after the company reported a Q4 EPS miss.
Achieve Life Sciences shares are trading lower after the company reported a Q4 ...
03-24 23:32
Achieve Life Sciences Q4 EPS $(0.28) Misses $(0.27) Estimate
Achieve Life Sciences (NASDAQ:ACHV) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.27) by 5.26 percent. This is a 22.22 percent increase over losses of $(0.36) per share
03-24 19:31
Earnings Scheduled For March 24, 2026
Companies Reporting Before The Bell • Fennec Pharmaceuticals (NASDAQ:FENC) is e...
03-24 19:11
Achieve Life Sciences Announces New Data On Cytisinicline As Smoking Cessation
Achieve also announces late-breaking survey data from ORCA-OL, demonstrating participant experience with extended cytisinicline use. These findings will be presented during the Society for Research on Nicotine &
03-04 21:07
Watching Achieve Life Sciences; Shares Trading Higher, Hunterbrook Media Issues Report On Co, States Hunterbrook Capital Is Long
https://hntrbrk.com/achieve/
2025-12-31 00:17
Achieve Life Sciences Announced Granting of New Hire Inducement Awards
Achieve Life Sciences, Inc. granted stock options to its Chief Legal Officer, Erik Atkisson, and two other new employees as an inducement to employment. Mr. Atkisson received options to purchase up to 250,000 shares, while the other employees collectively received options for 45,000 shares. The options vest over four years, with the first quarter vesting on the first anniversary of employment and the remaining shares vesting monthly thereafter. A...
2025-12-08 21:10
